# OnCo record tricision-biotherapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/tricision-biotherapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "tricision-biotherapeutics" ;
  schema:name "Tricision Biotherapeutics"@en ;
  schema:alternateName "Beijing Tricision Biotherapeutics Inc"@en, "北京启辰生生物科技有限公司"@en, "Tricision"@en ;
  schema:description "Tricision is a Beijing company working on mRNA medicines and cancer vaccines. Its lead cancer product is a vaccine made from a patient's own immune cells loaded with survivin, a protein found in glioblastoma, given after diagnosis."@en ;
  schema:url <https://onco.cc/companies/tricision-biotherapeutics/>, <https://tricisionbio.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://tricisionbio.com/>, <https://clinicaltrials.gov/study/NCT06524063>, <https://clinicaltrials.gov/study/NCT07715097> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/dendritic-cell-vaccines/> ;
  onco:targets <https://onco.cc/targets/birc5/> .